AI 检索
AI 阅读
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing's disease.

Richard A Feelders,Maria Fleseriu,Pinar Kadioglu,Marie Bex, Deyanira González-Devia,Cesar Luiz Boguszewski,Dilek Gogas Yavuz, Heather Patino,Alberto M Pedroncelli,Ricardo Maamari,Arghya Chattopadhyay,Beverly M K Biller,Rosario Pivonello

Frontiers in endocrinology（2023）

引用 0|浏览14
暂无评分
摘要
https://clinicaltrials.gov/ct2/show/NCT01915303, identifier NCT01915303.
更多
查看译文
关键词
somatostatin, pasireotide, cabergoline, Cushing's disease, hypercortisolism
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要